Vimarsana
Biggest News Aggregation in the World

Page 39 - Acceleron Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acceleron Pharma Today - Breaking & Trending Today

2 High-Yield Dividend Stocks That Can Safeguard Your Portfolio Against Inflation - Vimarsana News

2 High-Yield Dividend Stocks That Can Safeguard Your Portfolio Against Inflation

These two big pharma stocks are outstanding value and income vehicles.

Source: fool.com
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors - Vimarsana News

Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors

Arcturus Therapeutics Holdings Inc. , a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and... | December 13, 2021

The ecosystem overtakes the producers in pharma and life sciences - Vimarsana News

The ecosystem overtakes the producers in pharma and life sciences

M&A returns – but in a new form - Magazine Article - PharmaTimes

Merck's Keytruda FDA approval as adjuvant therapy for melanoma patients - Vimarsana News

Merck's Keytruda FDA approval as adjuvant therapy for melanoma patients

Merck’s Keytruda, has obtained approval from the US FDA as an adjuvant therapy for stage IIB or IIC melanoma patients aged 12 years and above.

10 Best Healthcare Stocks to Buy According to Greg Martinez's Parkman Healthcare Partners - Vimarsana News

10 Best Healthcare Stocks to Buy According to Greg Martinez's Parkman Healthcare Partners

In this article, we discuss the 10 best healthcare stocks to buy according to Greg Martinez's Parkman Healthcare Partners.